| Enhancer ID: | E_02_0524 |
| Species: | human |
| Position : | chr9:104777916-104779916 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Atherosclerosis |
| Pubmed ID: | 30018722 |
| Enhancer experiment: | ELISA, Western blot, immunohistochemistry, flow cytometry, immunofluorescence staining, oil-red-O staining, statistical analysis |
| Enhancer experiment description: | Furthermore, dramatically increased the expression of Fc receptors (FcR) on peripheral blood mononuclear macrophages, suggesting that the mechanism of phagocytosis of ox-LDL by mononuclear macrophages may rely more on FcR than the cluster of differentiation 36 (CD36) scavenger receptor with P210-Ab. Both in vitro and in vivo, P210-Ab triggered the promoter of ATP-binding cassette transporter A1 (ABCA1) to increase peroxisome proliferator-activated receptor alpha (?) activity and inhibit the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) pathway. |
| Target gene : | ABCA1 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Furthermore, dramatically increased the expression of Fc receptors (FcR) on peripheral blood mononuclear macrophages, suggesting that the mechanism of phagocytosis of ox-LDL by mononuclear macrophages may rely more on FcR than the cluster of differentiation 36 (CD36) scavenger receptor with P210-Ab. Both in vitro and in vivo, P210-Ab triggered the promoter of ATP-binding cassette transporter A1 (ABCA1) to increase peroxisome proliferator-activated receptor alpha (?) activity and inhibit the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) pathway. |
| TF name : | -- |
| TF experiment: | ELISA,Western blot,Immunohistochemistry,?????,??????,Oil-red-O staining,???? |
| TF experiment description: | Furthermore, dramatically increased the expression of Fc receptors (FcR) on peripheral blood mononuclear macrophages, suggesting that the mechanism of phagocytosis of ox-LDL by mononuclear macrophages may rely more on FcR than the cluster of differentiation 36 (CD36) scavenger receptor with P210-Ab. Both in vitro and in vivo, P210-Ab triggered the promoter of ATP-binding cassette transporter A1 (ABCA1) to increase peroxisome proliferator-activated receptor alpha (?) activity and inhibit the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) pathway. |
| Enhancer function : | Furthermore, dramatically increased the expression of Fc receptors (FcR) on peripheral blood mononuclear macrophages, suggesting that the mechanism of phagocytosis of ox-LDL by mononuclear macrophages may rely more on FcR than the cluster of differentiation 36 (CD36) scavenger receptor with P210-Ab. Both in vitro and in vivo, P210-Ab triggered the promoter of ATP-binding cassette transporter A1 (ABCA1) to increase peroxisome proliferator-activated receptor alpha (?) activity and inhibit the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) pathway. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Furthermore, dramatically increased the expression of Fc receptors (FcR) on peripheral blood mononuclear macrophages, suggesting that the mechanism of phagocytosis of ox-LDL by mononuclear macrophages may rely more on FcR than the cluster of differentiation 36 (CD36) scavenger receptor with P210-Ab. Both in vitro and in vivo, P210-Ab triggered the promoter of ATP-binding cassette transporter A1 (ABCA1) to increase peroxisome proliferator-activated receptor alpha (?) activity and inhibit the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) pathway. |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|